Utility of Cell death-associated Proteins as Serum Biomarkers to Predict Short-term Outcomes of Neonatal Encephalopathy and Cooling

Raul Chavez-Valdez, Johns Hopkins University School of Medicine, Baltimore, MD, United States; Lauren Jantzie, Johns Hopkins University School of Medicine, Baltimore, MD, United States; Charlamaine Parkinson, Johns Hopkins Children's Center, Baltimore, MD, United States; Ernest Graham, Johns Hopkins University School of Medicine, Crownsville, MD, United States; Khyzer B. Aziz, Johns Hopkins University School of Medicine, Baltimore, MD, United States; Cedric Manlhiot, The Hospital for Sick Children, Toronto, ON, Canada; Gwendolyn Gerner, Kennedy Krieger Institute, Baltimore, MD, United States; Jordan R. Kuiper, George Washington University Milken Institute School of Public Health, Washington, DC, United States; Santina Zanelli, University of Virginia, Charlottesville, VA, United States; Jennifer Burnsed, University of Virginia School of Medicine, Charlottesville, VA, United States; Vivek V. Shukla, University of Alabama at Birmingham, Birmingham, AL, United States; Allen Everett, johns hopkins, Glenwood, MD, United States; Frances Northington, Johns Hopkins University School of Medicine, Baltimore, MD, United States